Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amano Enzyme is a premier global manufacturer of specialty enzymes for the pharmaceutical, diagnostic, and food industries. Founded in 1899 as Amano Pharmaceutical, the company has evolved into a specialized biotechnology firm focused on microbial enzyme production. Headquartered in Nagoya, Japan, it maintains a significant international presence with subsidiaries in the United States, United Kingdom, and China. The company's pharmaceutical portfolio includes high-quality digestive enzymes such as lipases, proteases, and amylases used in enzyme replacement therapies. Amano also provides critical enzymes for clinical diagnostic kits and biopharmaceutical manufacturing processes. With a strong emphasis on R&D, the company utilizes advanced fermentation technology to develop customized enzyme solutions for global clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amano Pharmaceutical.